Immunology Pipeline

Immunology/Immuno-oncology Programs


  • AVTX-002, a fully human anti-LIGHT, monoclonal antibody for the treatment of acute respiratory distress syndrome (ARDS) across a variety of etiologies and for the treatment of inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis.Learn More >

Still’s Disease

  • AVTX-007, a fully human anti-IL-18 monoclonal antibody with the potential to address multiple immune-mediated diseases, including Still’s disease and certain cancers like relapsed or refractory multiple myeloma.Learn More >